INNOVATE Corp (VATE) Actualités

INNOVATE Corp. to Report Fourth Quarter and Full Year 2024 Results on March 31st

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”...

Form 8-K - Current report

MediBeacon® Transdermal GFR System receives device approval in China

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in...

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

INNOVATE Corp. Portfolio Company R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- R2 Technologies, Inc., the world leader in CryoAesthetics® with...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

INNOVATE Corp. Announces Third Quarter 2024 Results

- Infrastructure: DBM Global third quarter revenue of $232.8 million -- Life Sciences: R2 reports record...

Form 4 - Statement of changes in beneficial ownership of securities